Cord blood transplant offers new hope for rare EBV diseases

NCT ID NCT07381738

Recruiting now Disease control Sponsor: Fudan University Source: ClinicalTrials.gov ↗

First seen Feb 02, 2026 · Last updated Jun 14, 2026 · Updated 17 times

Summary

This study tests whether a transplant of donated umbilical cord blood can help people aged 14 to 80 with serious diseases caused by the Epstein-Barr virus (EBV), such as certain lymphomas or chronic active EBV infection. The goal is to control the disease and improve survival, but lifelong monitoring or additional treatment may still be needed. About 80 participants will receive the transplant and be followed for side effects and response.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Huadong hospital, Fudan university
RECRUITING

Shanghai, Shanghai Municipality, 200040, China

Contact Phone: •••-•••-•••• Email: •••••@•••••
Huashan Hospital, Fudan University
RECRUITING

Shanghai, Shanghai Municipality, 200040, China

Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.

CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EBV ASSOCIATED LYMPHOMA EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISEASES UMBILICAL CORD BLOOD TRANSPLANT